ONWARD Medical B.V. Registered Aktie

4,04 EUR +0,23 EUR +5,90 %

16:31:59

STU

3,96 EUR +0,04 EUR +0,89 %

07.11.2025

ASX

ONWARD Medical B.V. Registered jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.221,79 Mio. EUR

Div. Rendite0,00%

WKNA3C5RE

ISINNL0015000HT4

SymbolONWRF

ONWARD Medical B.V. Registered Aktien News

Sortieren:Datum Meistgelesen

11.06.25GlobeNewswireONWARD Medical Announces Results of its Annual General Meeting of Shareholders

11.06.25GlobeNewswireONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights

21.05.25GlobeNewswireONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants

WerbungONWARD Medical B.V. Registered-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

30.04.25GlobeNewswireONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions

28.04.25GlobeNewswireONWARD Medical Announces Release of 2024 Annual Report

24.04.25GlobeNewswireONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market

01.04.25GlobeNewswireONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights

26.03.25GlobeNewswireONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility

19.03.25GlobeNewswireONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast

04.03.25GlobeNewswireONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense

25.02.25GlobeNewswireONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy

29.01.25GlobeNewswireONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms

13.01.25GlobeNewswireONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

09.01.25GlobeNewswireONWARD Medical Announces First Commercial Sales of ARC-EX System

19.12.24GlobeNewswireONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

12.12.24GlobeNewswireONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

26.11.24GlobeNewswireONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

19.11.24GlobeNewswireONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

12.11.24GlobeNewswireONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

31.10.24GlobeNewswireONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024

28.10.24GlobeNewswireONWARD® Medical Publishes Closing of Bookbuild Offering

24.10.24GlobeNewswireONWARD® Medical Publishes Prospectus for Listing of New Shares

24.10.24GlobeNewswireONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA

22.10.24GlobeNewswireONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA

21.10.24GlobeNewswireONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman

15.10.24GlobeNewswireONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology

19.09.24GlobeNewswireONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury

10.09.24GlobeNewswireONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update

03.09.24GlobeNewswireONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System

27.08.24GlobeNewswireONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update

05.08.24GlobeNewswireONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights

17.07.24GlobeNewswireONWARD® Medical Publishes Annual Sustainability Summary

09.07.24GlobeNewswireONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy

28.06.24GlobeNewswireONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

26.06.24GlobeNewswireONWARD® Medical Announces Participation in Stifel European Healthcare Summit

18.06.24GlobeNewswireONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference

13.06.24GlobeNewswireONWARD® Medical Announces Results of Annual General Meeting of Shareholders

23.05.24GlobeNewswireONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

21.05.24GlobeNewswireONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication

20.05.24GlobeNewswireNature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy

ONWARD Medical B.V. Registered News

ONWARD Medical B.V. Registered News: auf dieser Seite finden Sie alle ONWARD Medical B.V. Registered News und Nachrichten zur ONWARD Medical B.V. Registered Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch ONWARD Medical B.V. Registered News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um ONWARD Medical B.V. Registered News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.